Literature DB >> 14226126

PHASE II STUDY OF A-8103 (NSC-25154) IN ACUTE LEUKEMIA IN ADULTS.

J S HEWLETT, J D BATTLE, R C BISHOP, W M FOWLER, S O SCHWARTZ, P S HAGEN, J LOUIS.   

Abstract

Entities:  

Keywords:  ADOLESCENCE; ANTINEOPLASTIC AGENTS; DRUG THERAPY; GERIATRICS; LEUKEMIA; PHARMACOLOGY; PIPERAZINES; TOXICOLOGIC REPORT

Mesh：

Substances：

Year:  1964        PMID： 14226126

Source DB:  PubMed          Journal:  Cancer Chemother Rep        ISSN： 0069-0112


× No keyword cloud information.
  7 in total

1.  Remission of acute myelogenous leukemia complicating Waldenström macroglobulinemia.

Authors:  M K Effron; J Rosenbaum; P L Greenberg
Journal:  West J Med       Date:  1978-10

2.  [Clinico-pharmacologic, cytochemical and Feulgen photometric studies in adult undifferentiated cell leukemias under combination chemotherapy with vincristine, daunorubicine and prednisone].

Authors:  P Obrecht; H Merker; H H Hennekeuser; G Meuret; M Westerhausen; A Simon
Journal:  Klin Wochenschr       Date:  1970-11-01

3.  Pharmacokinetic and phase I study of intravenous DON (6-diazo-5-oxo-L-norleucine) in children.

Authors:  M P Sullivan; J A Nelson; S Feldman; B Van Nguyen
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

4.  Toxicity trials of amsacrine (AMSA) and etoposide +/- azacitidine (AZ) in childhood acute non-lymphocytic leukemia (ANLL): a pilot study.

Authors:  C P Steuber; T Holbrook; B Camitta; V J Land; C Sexauer; J Krischer
Journal:  Invest New Drugs       Date:  1991-05       Impact factor: 3.850

5.  Therapy of acute myelocytic leukemia. Daunomycin contrasted with a combination of cytosine arabinoside and 6-thioguanine.

Authors:  J L Poth; P K Johnson; R P George; S L Schrier
Journal:  Calif Med       Date:  1972-12

6.  Remission maintenance therapy in acute myelogenous leukemia.

Authors:  S H Embury; L Elias; P H Heller; C E Hood; P L Greenberg; S L Schrier
Journal:  West J Med       Date:  1977-04

7.  Early central nervous system involvement in adults with acute non-myelogenous leukaemia.

Authors:  T A Lister; J M Whitehouse; M E Beard; A Paxton; R L Brearley; L Brown; P F Wrigley; D Crowther
Journal:  Br J Cancer       Date:  1977-04       Impact factor: 7.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.